While previous studies have explored the effects of targeted therapies, particularly tumor necrosis factor (TNF) inhibitors, on bone remodeling in RA, limited research has investigated the impact of abatacept on bone remodeling and bone modulators11–14. The gene discussed is TNF; the disease is rheumatoid arthritis.